A Phase IIa Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication.
Phase of Trial: Phase II
Latest Information Update: 21 Mar 2012
At a glance
- Drugs Cilostazol; K 134
- Indications Embolism and thrombosis; Intermittent claudication
- Focus Therapeutic Use
- 21 Mar 2012 Actual patient number is 387 according to ClinicalTrials.gov.
- 10 Nov 2011 Results were reported at the American Heart Association Scientific Sessions, according to a Kowa media release.
- 01 Jul 2010 Status changed from active, no longer recruiting to completed.